Back to search
FDAFDA · Food and drugs·Recall number Z-2607-2016

Radiesse (+) Lidocaine, Injectable Implant 1.5cc, Rx only, P/N: 8063M0K1, Merz Aesthetics. Product Usage: RADIESSE is indicated for sub-dermal implantation for the correction of moderate to severe facial wrinkles and folds.

Published August 31, 2016 · Recall initiated: May 20, 2016

Summary

FDA records medical device Class II recall Z-2607-2016, published August 31, 2016 and initiated May 20, 2016. Recalling firm: Merz North America, Inc.; Status: Terminated; Reported quantity: 1,591 units; Lot: Model number: 8063M0K1, Lot #100088744. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Merz North America, Inc.
Distributor
US Nationwide Distribution in the states of AR, CA, CO, CT, DC, FL, GA, IL, IN, LA, MA, MD, MI, MN, MO, NC, ND, NJ, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT and WA.
Lot
Model number: 8063M0K1, Lot #100088744.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Radiesse (+) Lidocaine, Injectable Implant 1.5cc, Rx only, P/N: 8063M0K1, Merz Aesthetics. Product Usage: RADIESSE is indicated for sub-dermal implantation for the correction of moderate to severe facial wrinkles and folds. recalled?

Yes. FDA published recall Z-2607-2016 on August 31, 2016. Reported hazard: Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.

What should I do if I have this product?

Voluntary: Firm initiated · Letter